Novoron Bioscience

Novoron Bioscience is a private biotech company developing novel approaches to treat disorders of the central nervous system. Unlike nerves in the body, nerves and surrounding tissue in the brain and spinal cord fail to repair themselves after damage. This results in permanent disabilities such as paralysis and loss of sensation. Their work has led to the discovery of new drugs that have demonstrated the ability to restore the healing capacity of the brain and spinal cord, with the potential to reverse the paralysis and disability caused by damage and disease.

Novoron is focused on reversing the damage in spinal cord injury and multiple sclerosis. Their preclinical studies have shown a remarkable ability to restore healing that is otherwise lost in these conditions. With an innovative approach to repairing neural tissue, Novoron has secured four independent federal grants from the National Institute of Health (NIH), totaling just over $2 million in non-dilutive funding for their drug development programs.

Novoron is headquartered in San Diego, CA, in the JLABS incubator, a part of Johnson & Johnson Innovation.